Bio Protocol vs GoPlus Security — how do they compare? Bio Protocol trades at Rp517.33 (market cap Rp1,15T, Rp264,79M 24h volume), while GoPlus Security trades at Rp178.17 (market cap Rp936,16M, Rp86,56M 24h volume). The key difference: Bio Protocol is far larger — about 1228.4× GoPlus Security's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 5,3B / 10B GPS (53%) for GoPlus Security. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and GoPlus Security for 10 Days on average.
| BIO | GPS | |
|---|---|---|
Market Cap | Rp1,15T | Rp936,16M |
Volume (24h) | Rp264,79M | Rp86,56M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 5,3B / 10B GPS (53%) |
Typical Hold Time | 16 Days | 10 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
GoPlus Security (GPS) trades at Rp178.32 with a market cap of Rp936.16M, showing a bullish technical signal supported by moving averages. The token is near pivot point support at Rp179, with key resistance at Rp190. RSI_6 at 76.93 indicates potential overbought conditions, while ADX signals strong trend strength. No major protocol updates or ecosystem developments were noted recently.
Overall outlook is cautiously optimistic due to technical strength, but high RSI and limited fundamental catalysts pose risks. Key opportunities include breakout above Rp190, while risks involve overbought correction and low liquidity. Investors should monitor volume and on-chain activity for confirmation.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →GoPlus Security is creating the first decentralized security layer for Web3, providing comprehensive protection across all blockchain networks. Its open, permissionless, and user-driven architecture allows for seamless integration into any blockchain or project, ensuring user safety throughout the entire transaction lifecycle.
Read more on GPS →